Glowing dye may make pancreatic surgery safer

NCT ID NCT07656571

Recruiting now Disease control Sponsor: Alexandria University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This trial compares two types of keyhole surgery to remove the tail of the pancreas. One uses a dye called indocyanine green that glows under special lights, helping surgeons see blood flow and decide where to cut. The other is the standard procedure without the dye. The goal is to see if the dye reduces the risk of a pancreatic fistula, a common and serious leak of digestive fluids. Adults needing this surgery for tumors in the body or tail of the pancreas may join.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: indocyanine green (ICG) dye
What this could lead to: If it works, this could make laparoscopic pancreatic surgery safer by reducing the risk of a serious complication called pancreatic fistula.
What could go wrong: This is a relatively small, early-stage trial, so results may not apply to all patients. The dye may not improve outcomes, and there are always risks from surgery itself.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

malignant pancreatic neoplasm pancreatic neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PANCREATIC CANCER PANCREATIC NEOPLASMS

Contacts and locations

Locations

Faculty of Medicine, Alexandria University
RECRUITING

Alexandria, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.